1. Home
  2. RH vs PVLA Comparison

RH vs PVLA Comparison

Compare RH & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RH

RH

RH

N/A

Current Price

$133.78

Market Cap

2.2B

ML Signal

N/A

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

N/A

Current Price

$165.87

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RH
PVLA
Founded
1979
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
RH
PVLA
Price
$133.78
$165.87
Analyst Decision
Hold
Strong Buy
Analyst Count
20
16
Target Price
$164.41
★ $233.80
AVG Volume (30 Days)
★ 752.4K
248.4K
Earning Date
12-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 74.31
52.62
EPS
★ 2.36
N/A
Revenue
★ $1,193,046,000.00
$42,810,000.00
Revenue This Year
$5.68
N/A
Revenue Next Year
$9.26
N/A
P/E Ratio
$57.18
★ N/A
Revenue Growth
24.52
★ 65.28
52 Week Low
$106.30
$72.23
52 Week High
$239.40
$179.95

Technical Indicators

Market Signals
Indicator
RH
PVLA
Relative Strength Index (RSI) 50.18 63.60
Support Level $123.55 $139.09
Resistance Level $137.90 N/A
Average True Range (ATR) 8.20 10.17
MACD -0.28 4.29
Stochastic Oscillator 30.36 76.68

Price Performance

Historical Comparison
RH
PVLA

About RH RH

RH is a luxury furniture and lifestyle retailer primarily operating in the $136 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories, including furniture, lighting, textiles, bath, decor, and has a growing presence in hospitality with 27 restaurant locations, including RH Guesthouse. RH innovates, curates, and integrates products, categories, services, and businesses across design subcategories (RH Estates and Waterworks, for example), and has recently broadened its addressable market via expansion abroad (currently, less than 10% of sales) and its World of RH digital platform (highlighting offerings outside of home furnishings).

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: